Cartilage Degeneration Market 2025 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Cartilage Degeneration Market to 2025 - Global Analysis and Forecasts By Procedure Type (Osteochondral Transplant, Chondroplasty, Joint Replacement, Meniscus Transplants, Cell-based Cartilage Resurfacing, Autologous Chondrocyte Implantation and Others), Application (Knee, Hips and Others), End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers and Academic & Research Institutes) and Geography

Report Code: TIPMD00002230 | No. of Pages: 153 | Category: Medical Device | Status: Upcoming
Cartilage is a smooth, rubbery connective tissue that provides a smooth surface for joint motion. Cartilage found on the end of each bone such as ends of the ribs, ears & nose and between elbows, knees & ankles. Cartilage helps to stabilize joints and absorbs the force for easy movement. Due to some reasons, the body started to lose the cartilage component. When the water content increases, the protein makeup of cartilage degenerates. In turn, joint pain and swelling occur that leads to serious health issues including friction between the bones and limitation of joint mobility. The damage generally occurs after accidental injury or trauma to joints such as hips or knees.

The market of cartilage degeneration is anticipated to grow with a significant rate in the forecast period, owing to factors such as, increasing global geriatric population and rise in the number of industrial mishaps help to propel the cartilage degeneration. Moreover, increasing number of road accidents and rising rate of sports injuries are other factors which can drive the cartilage degeneration market. On other hand the increased R&D spending in emerging economies for advancements in knee cartilage repair to offer sustained growth opportunity of cartilage degeneration market.

The “Global Cartilage Degeneration Market Analysis to 2025” is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global cartilage degeneration market with detailed market segmentation by procedure type, application, end-user and geography. The global cartilage degeneration market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The global cartilage degeneration market is segmented on the basis of procedure type, application and end-user. The cartilage degeneration market is segmented into osteochondral transplant, chondroplasty, joint replacement, meniscus transplants, cell-based cartilage resurfacing, autologous chondrocyte implantation and others, by procedure. On the basis of application, the cartilage degeneration market is classified as knee, hips and others. Based on end user, the market is categorized into hospitals & specialty clinics, academic & research institutes and ambulatory surgical centers.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cartilage degeneration market based on procedure type, application and end-user. It also provides market size and forecast till 2025 for overall cartilage degeneration market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is anticipated to capture largest market share, owing to the well developed and established healthcare industry and increasing incidence of sports injuries in this region. However, the Asia-Pacific region is expected to fastest market growth in the coming years due to increasing rapid economic growth in countries such as, China, India, & Japan and increasing geriatric population in this region.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key cartilage degeneration manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Zimmer Biomet, Medtronic, Osiris Therapeutics, Inc., DePuy Synthes, Anika Therapeutics, Inc., CONMED Corporation., Arthrex, Inc., B. Braun Melsungen AG, Stryker and SmithNephewplc among others.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. CARTILAGE DEGENERATION MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Cartilage Degeneration Market - By Procedure Type
3.2.2. Cartilage Degeneration Market - By Application
3.2.3. Cartilage Degeneration Market - By End User
3.2.4. Cartilage Degeneration Market - By Region
3.2.4.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis

4. CARTILAGE DEGENERATION MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS

5. CARTILAGE DEGENERATION MARKET - GLOBAL ANALYSIS
5.1. GLOBAL CARTILAGE DEGENERATION MARKET OVERVIEW
5.2. GLOBAL CARTILAGE DEGENERATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. EXPERT OPINIONS

6. CARTILAGE DEGENERATION MARKET- GLOBAL REGULATORY SCENARIO
6.1. OVERVIEW
6.2. NORTH AMERICA
6.3. EUROPE
6.4. ASIA PACIFIC
6.5. MIDDLE EAST & AFRICA
6.6. SOUTH AND CENTRAL AMERICA

7. CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS TO 2025 - BY PROCEDURE TYPE
7.1. OVERVIEW
7.2. PROCEDURE TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. OSTEOCHONDRAL TRANSPLANT MARKET
7.3.1. Overview
7.3.2. Osteochondral Transplant Market Revenue Forecasts and Analysis (US$ Mn)
7.4. CHONDROPLASTY MARKET
7.4.1. Overview
7.4.2. Chondroplasty Market Revenue Forecasts and Analysis (US$ Mn)
7.5. JOINT REPLACEMENT MARKET
7.5.1. Overview
7.5.2. Joint Replacement Market Revenue Forecasts and Analysis (US$ Mn)
7.6. CELL-BASED CARTILAGE RESURFACING MARKET
7.6.1. Overview
7.6.2. Cell-based Cartilage Resurfacing Market Revenue Forecasts and Analysis (US$ Mn)
7.7. AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET
7.7.1. Overview
7.7.2. Autologous Chondrocyte Implantation Market Revenue Forecasts and Analysis (US$ Mn)
7.8. OTHERS MARKET
7.8.1. Overview
7.8.2. Others Market Revenue Forecasts and Analysis (US$ Mn)

8. CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS TO 2025 - BY APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. KNEE MARKET
8.3.1. Overview
8.3.2. Knee Market Revenue Forecasts and Analysis (US$ Mn)
8.4. HIPS MARKET
8.4.1. Overview
8.4.2. Hips Market Revenue Forecasts and Analysis (US$ Mn)
8.5. OTHER APPLICATIONS MARKET
8.5.1. Overview
8.5.2. Other Applications Market Revenue Forecasts and Analysis (US$ Mn)

9. CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS TO 2025 - BY END USER
9.1. OVERVIEW
9.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
9.3. HOSPITALS & SPECIALTY CLINICS MARKET
9.3.1. Overview
9.3.2. Hospitals & Specialty Clinics Market Revenue Forecasts and Analysis (US$ Mn)
9.4. ACADEMIC & RESEARCH INSTITUTES MARKET
9.4.1. Overview
9.4.2. Academic & Research Institutes Market Revenue Forecasts and Analysis (US$ Mn)
9.5. AMBULATORY SURGICAL CENTERS MARKET
9.5.1. Overview
9.5.2. Ambulatory Surgical Centers Market Revenue Forecasts and Analysis (US$ Mn)

10. NORTH AMERICA CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
10.1. NORTH AMERICA CARTILAGE DEGENERATION MARKET OVERVIEW
10.2. NORTH AMERICA CARTILAGE DEGENERATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. NORTH AMERICA CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS ANALYSIS - BY PROCEDURE TYPE (US$ MN)
10.4. NORTH AMERICA CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
10.5. NORTH AMERICA CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.6. NORTH AMERICA CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY

10.7. US MARKET OVERVIEW
10.7.1. US Cartilage Degeneration Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
10.7.2. US Cartilage Degeneration Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.7.3. US Cartilage Degeneration Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. CANADA MARKET OVERVIEW
10.8.1. Canada Cartilage Degeneration Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
10.8.2. Canada Cartilage Degeneration Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.8.3. Canada Cartilage Degeneration Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.9. MEXICO MARKET OVERVIEW
10.9.1. Mexico Cartilage Degeneration Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
10.9.2. Mexico Cartilage Degeneration Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.9.3. Mexico Cartilage Degeneration Market Revenue Forecasts and Analysis - By End User (US$ Mn)

11. EUROPE CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
11.1. EUROPE CARTILAGE DEGENERATION MARKET OVERVIEW
11.2. EUROPE CARTILAGE DEGENERATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. EUROPE CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS ANALYSIS - BY PROCEDURE TYPE (US$ MN)
11.4. EUROPE CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
11.5. EUROPE CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.6. EUROPE CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY

11.7. UK MARKET OVERVIEW
11.7.1. UK Cartilage Degeneration Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
11.7.2. UK Cartilage Degeneration Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.7.3. UK Cartilage Degeneration Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. GERMANY MARKET OVERVIEW
11.8.1. Germany Cartilage Degeneration Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
11.8.2. Germany Cartilage Degeneration Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.8.3. Germany Cartilage Degeneration Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.9. FRANCE MARKET OVERVIEW
11.9.1. France Cartilage Degeneration Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
11.9.2. France Cartilage Degeneration Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.9.3. France Cartilage Degeneration Market Revenue Forecasts and Analysis - By End User (US$ Mn)

12. ASIA PACIFIC CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
12.1. ASIA PACIFIC CARTILAGE DEGENERATION MARKET OVERVIEW
12.2. ASIA PACIFIC CARTILAGE DEGENERATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. ASIA PACIFIC CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS ANALYSIS - BY PROCEDURE TYPE (US$ MN)
12.4. ASIA PACIFIC CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
12.5. ASIA PACIFIC CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.6. ASIA PACIFIC CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY

12.7. JAPAN MARKET OVERVIEW
12.7.1. Japan Cartilage Degeneration Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
12.7.2. Japan Cartilage Degeneration Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.7.3. Japan Cartilage Degeneration Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.8. CHINA MARKET OVERVIEW
12.8.1. China Cartilage Degeneration Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
12.8.2. China Cartilage Degeneration Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.8.3. China Cartilage Degeneration Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.9. INDIA MARKET OVERVIEW
12.9.1. India Cartilage Degeneration Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
12.9.2. India Cartilage Degeneration Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.9.3. India Cartilage Degeneration Market Revenue Forecasts and Analysis - By End User (US$ Mn)

13. MIDDLE EAST AND AFRICA (MEA) CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
13.1. MIDDLE EAST AND AFRICA CARTILAGE DEGENERATION MARKET OVERVIEW
13.2. MIDDLE EAST AND AFRICA CARTILAGE DEGENERATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. MIDDLE EAST AND AFRICA CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS ANALYSIS - BY PROCEDURE TYPE (US$ MN)
13.4. MIDDLE EAST AND AFRICA CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
13.5. MIDDLE EAST AND AFRICA CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.6. MIDDLE EAST AND AFRICA CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY

13.7. SOUTH AFRICA MARKET OVERVIEW
13.7.1. South Africa Cartilage Degeneration Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
13.7.2. South Africa Cartilage Degeneration Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.7.3. South Africa Cartilage Degeneration Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13.8. SAUDI ARABIA MARKET OVERVIEW
13.8.1. Saudi Arabia Cartilage Degeneration Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
13.8.2. Saudi Arabia Cartilage Degeneration Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.8.3. Saudi Arabia Cartilage Degeneration Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13.9. UAE MARKET OVERVIEW
13.9.1. UAE Cartilage Degeneration Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
13.9.2. UAE Cartilage Degeneration Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.9.3. UAE Cartilage Degeneration Market Revenue Forecasts and Analysis - By End User (US$ Mn)

14. SOUTH AND CENTRAL AMERICA CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
14.1. SOUTH AND CENTRAL AMERICA CARTILAGE DEGENERATION MARKET OVERVIEW
14.2. SOUTH AND CENTRAL AMERICA CARTILAGE DEGENERATION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
14.3. SOUTH AND CENTRAL AMERICA CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS ANALYSIS - BY PROCEDURE TYPE (US$ MN)
14.4. SOUTH AND CENTRAL AMERICA CARTILAGE DEGENERATION MARKET VOLUME AND FORECASTS ANALYSIS - BY PROCEDURE TYPE (US$ MN)
14.5. SOUTH AND CENTRAL AMERICA CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
14.6. SOUTH AND CENTRAL AMERICA CARTILAGE DEGENERATION MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY

14.7. BRAZIL MARKET OVERVIEW
14.7.1. Brazil Cartilage Degeneration Market Revenue Forecasts and Analysis - By Procedure Type (US$ Mn)
14.7.2. Brazil Cartilage Degeneration Market Revenue Forecasts and Analysis - By Application (US$ Mn)
14.7.3. Brazil Cartilage Degeneration Market Revenue Forecasts and Analysis - By End User (US$ Mn)

15. INDUSTRY LANDSCAPE
15.1. ORGANIC GROWTH STRATEGIES
15.1.1. New Product Launches
15.1.2. Marketing & Promotional Activities
15.2. INORGANIC GROWTH STRATEGIES
15.2.1. Partnerships, Collaborations, and Joint Ventures
15.2.2. Mergers & Acquisitions

16. CARTILAGE DEGENERATION MARKET, KEY COMPANY PROFILES
16.1. Zimmer Biomet
16.1.1. Key Facts
16.1.2. Business Description
16.1.3. Financial Overview
16.1.4. Product Portfolio
16.1.5. Product Pipeline
16.1.6. SWOT Analysis
16.1.7. Key Developments
16.2. Medtronic
16.2.1. Key Facts
16.2.2. Business Description
16.2.3. Financial Overview
16.2.4. Product Portfolio
16.2.5. Product Pipeline
16.2.6. SWOT Analysis
16.2.7. Key Developments
16.3. Osiris Therapeutics, Inc.
16.3.1. Key Facts
16.3.2. Business Description
16.3.3. Financial Overview
16.3.4. Product Portfolio
16.3.5. Product Pipeline
16.3.6. SWOT Analysis
16.3.7. Key Developments
16.4. DePuy Synthes
16.4.1. Key Facts
16.4.2. Business Description
16.4.3. Financial Overview
16.4.4. Product Portfolio
16.4.5. Product Pipeline
16.4.6. SWOT Analysis
16.4.7. Key Developments
16.5. Anika Therapeutics, Inc.
16.5.1. Key Facts
16.5.2. Business Description
16.5.3. Financial Overview
16.5.4. Product Portfolio
16.5.5. Product Pipeline
16.5.6. SWOT Analysis
16.5.7. Key Developments
16.6. CONMED Corporation
16.6.1. Business Description
16.6.2. Financial Overview
16.6.3. Product Portfolio
16.6.4. Product Pipeline
16.6.5. SWOT Analysis
16.6.6. Key Developments
16.7. Arthrex, Inc.
16.7.1. Key Facts
16.7.2. Business Description
16.7.3. Financial Overview
16.7.4. Product Portfolio
16.7.5. Product Pipeline
16.7.6. SWOT Analysis
16.7.7. Key Developments
16.8. B. Braun Melsungen AG
16.8.1. Key Facts
16.8.2. Business Description
16.8.3. Financial Overview
16.8.4. Product Portfolio
16.8.5. Product Pipeline
16.8.6. SWOT Analysis
16.8.7. Key Developments
16.9. Stryker
16.9.1. Key Facts
16.9.2. Business Description
16.9.3. Financial Overview
16.9.4. Product Portfolio
16.9.5. Product Pipeline
16.9.6. SWOT Analysis
16.9.7. Key Developments
16.10. SmithNephewplc
16.10.1. Key Facts
16.10.2. Business Description
16.10.3. Financial Overview
16.10.4. Product Portfolio
16.10.5. Product Pipeline
16.10.6. SWOT Analysis
16.10.7. Key Developments

17. APPENDIX
17.1. ABOUT THE INSIGHT PARTNERS
17.2. GLOSSARY OF TERMS
17.3. RESEARCH METHODOLOGY
The List of Companies

1. Zimmer Biomet
2. Medtronic
3. Osiris Therapeutics, Inc.
4. DePuy Synthes
5. Anika Therapeutics, Inc.
6. CONMED Corporation.
7. Arthrex, Inc.
8. B. Braun Melsungen AG
9. Stryker
10. SmithNephewplc

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book